Sodium → HCID 178430498, compound
Reaction equation
Cl.[F:2][C:3]([F:22])([F:21])[CH2:4][N:5]=[C:6]([NH2:20])[NH:7][C:8]1[N:12]=[CH:11][N:10]([CH2:13][CH2:14][CH2:15][CH2:16][C:17]([NH2:19])=[NH:18])[N:9]=1.[Na].[CH:24]([CH:26]([CH3:32])[C:27](OCC)=O)=[O:25]>CO>[OH:25][C:24]1[C:26]([CH3:32])=[CH:27][N:19]=[C:17]([CH2:16][CH2:15][CH2:14][CH2:13][N:10]2[CH:11]=[N:12][C:8]([NH:7][C:6]([NH2:20])=[N:5][CH2:4][C:3]([F:2])([F:21])[F:22])=[N:9]2)[N:18]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 5-(3-[2-(2,2,2-trifluoroethyl)guanidino]-1,2,4-triazol-1-yl)valeramidine hydrochloride (1 g.) in MeOH (14 ml.) was treated with the sodium salt of ethyl 2-formylpropionate (1.95 g.) and the suspension heated under reflux for 3.5 hours. This suspension was evaporated and the residue partitioned between water and ether. The aqueous layer was acidified with glacial HOAc to pH 3 and further extracted with ether. Neutralisation with aqueous ammonia (s.g. 0.880) and extraction with EtOAc gave a white solid which was crystallised twice from acetonitrile to give 4-hydroxy-5-methyl-2-[4-(3-[2-(2,2,2-trifluoroethyl)guanidino]-1,2,4-triazol-1-yl)butyl]pyrimidine (0.127 g.; 12%), m.p. 235°-237°.
Workup
- temperaturethe suspension heated
- temperatureunder reflux for 3.5 hours
- customThis suspension was evaporated
- customthe residue partitioned between water and ether
- extractionfurther extracted with ether
- extractionNeutralisation with aqueous ammonia (s.g. 0.880) and extraction with EtOAc
- customgave a white solid which
- customwas crystallised twice from acetonitrile
Sources & evidence
- ORD record
- ord-4da51636c65d4d37b4e1a7b88965735d
- Source dataset
- uspto-grants-1989_01
- Patent number
- US04795755
Reaction notes
Loading…